John M. Evans - Net Worth and Insider Trading
John M. Evans Net Worth
The estimated net worth of John M. Evans is at least $25 Million dollars as of 2024-11-05. John M. Evans is the CEO of Beam Therapeutics Inc and owns about 1,041,659 shares of Beam Therapeutics Inc (BEAM) stock worth over $25 Million. Details can be seen in John M. Evans's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John M. Evans has not made any transactions after 2024-09-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John M. Evans
John M. Evans Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John M. Evans owns 2 companies in total, including Beam Therapeutics Inc (BEAM) , and Verve Therapeutics Inc (VERV) .
Click here to see the complete history of John M. Evans’s form 4 insider trades.
Insider Ownership Summary of John M. Evans
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BEAM | Beam Therapeutics Inc | 2024-09-30 | director & CEO |
| VERV | Verve Therapeutics Inc | 2021-06-16 | director |
John M. Evans Latest Holdings Summary
John M. Evans currently owns a total of 1 stock. John M. Evans owns 1,041,659 shares of Beam Therapeutics Inc (BEAM) as of September 30, 2024, with a value of $25 Million.
Latest Holdings of John M. Evans
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BEAM | Beam Therapeutics Inc | 2024-09-30 | 1,041,659 | 24.36 | 25,374,813 |
Holding Weightings of John M. Evans
John M. Evans Form 4 Trading Tracker
According to the SEC Form 4 filings, John M. Evans has made a total of 15 transactions in Beam Therapeutics Inc (BEAM) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in Beam Therapeutics Inc is the sale of 60,000 shares on September 30, 2024, which brought John M. Evans around $1 Million.
Insider Trading History of John M. Evans
- 1
John M. Evans Trading Performance
John M. Evans Ownership Network
Ownership Network List of John M. Evans
Ownership Network Relation of John M. Evans
John M. Evans Owned Company Details
What does Beam Therapeutics Inc do?
Who are the key executives at Beam Therapeutics Inc?
John M. Evans is the director & CEO of Beam Therapeutics Inc. Other key executives at Beam Therapeutics Inc include President & CSO Giuseppe Ciaramella , Chief Legal Officer Christine Bellon , and Chief Medical Officer Amy Simon .
Beam Therapeutics Inc (BEAM) Insider Trades Summary
Over the past 18 months, John M. Evans made 4 insider transaction in Beam Therapeutics Inc (BEAM) with a net sale of 198,102. Other recent insider transactions involving Beam Therapeutics Inc (BEAM) include a net sale of 16,081 shares made by Christine Bellon , a net sale of 28,776 shares made by Amy Simon , and a net sale of 212,174 shares made by Giuseppe Ciaramella .
In summary, during the past 3 months, insiders sold 111,784 shares of Beam Therapeutics Inc (BEAM) in total and bought 0 shares, with a net sale of 111,784 shares. During the past 18 months, 1,362,433 shares of Beam Therapeutics Inc (BEAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,362,433 shares.
Beam Therapeutics Inc (BEAM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Beam Therapeutics Inc Insider Transactions
John M. Evans Mailing Address
Above is the net worth, insider trading, and ownership report for John M. Evans. You might contact John M. Evans via mailing address: C/o Beam Therapeutics Inc., 26 Landsdowne Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
